Loading candles…
Indrayani Biotech Ltd, incorporated in 1992 in India, is a diversified company operating across multiple industries including foods and hospitality, engineering, healthcare, and biotech-related services. It serves both institutional and retail markets through a variety of business units and subsidiaries, functioning as a multi-divisional conglomerate. The company emphasizes an inclusive growth strategy with decentralized management, where individual business heads oversee specialized segments. Over time, Indrayani Biotech has evolved from its original focus to a broader industrial and service-oriented portfolio.
This page is a live market overview for INDRAYANI BIOTECH LTD. (INDRANIB) on the BSE. As a listed security, INDRAYANI BIOTECH LTD. is tracked in the Fast Moving Consumer Goods segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INDRANIB before placing trades on tick2trade.
As of the latest feed, INDRANIB last traded at ₹8.72 on BSE, up ₹0.49 (5.95%) from the previous close of ₹8.23. Today's session range is ₹8.33 – ₹8.85, against a 52-week band of ₹8.33 – ₹41. Traded volume today stands at 1.54L shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for INDRANIB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INDRANIB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INDRAYANI BIOTECH LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INDRANIB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INDRANIB option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.